Production is primarily focused on chemistry of heterocyclic compounds using common types of reactions (including Grignard reactions) in production areas complying with the Good Manufacturing Practice. This production is conducted in enamel and stainless reactors of up to 6300 litres, in auxiliary production equipment, in centrifuges, in dryers, and on filter dryers. The final part of the production process lies in sieving, grounding, sometimes micronization, and lastly in packaging. Production units are subject to inspections by state drug agency SUKL and sometimes even to FDA audits.
A part of the company’s strategy is an Integrated policy of quality, environment, and the prevention of serious accidents. Quality control complies with the GMP requirements. The production process is subject to regular inspections of the State Institute for Drug Control (SUKL), inspections conducted by the American Food and Drug Administration (FDA), and customer audits.
FARMAK a.s. has an incorporated and certified quality and environment assurance system in accordance with legislative standards ČSN EN ISO 9001 and ČSN EN ISO 14001.
FARMAK a.s. devotes a great deal of its efforts to the preservation of environment, health and safety standards and has been a multiple holder of the RESPONSIBLE CARE certification.
Currently, FARMAK a.s. is employing over 240 employees meeting high qualification and education requirements.